" THALASSEMIA N ME

Saturday, January 11, 2014



Biogen Idec forges a $320M gene editing deal aimed at curing inherited blood disorders
http://www.fiercebiotech.com/story/biogen-idec-forges-320m-gene-editing-deal-aimed-curing-inherited-blood-diso/2014-01-09

Sangamo BioSciences
http://www.sangamo.com/

No comments:

Post a Comment